French agency head to leave over delayed withdrawal of slimming pill
This article was originally published in Clinica
Executive Summary
Jean Marimbert, the head of the French drug and device regulatory agency (Afssaps), is resigning from his post in the face of growing criticism from the general public that the agency took too long to withdraw a controversial slimming drug from the market.